153 related articles for article (PubMed ID: 38336746)
1. PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model.
Yuan S; Gao M; Wang Y; Lan Y; Li M; Du Y; Li Y; Ju W; Huang Y; Yuan K; Zeng L
Cancer Cell Int; 2024 Feb; 24(1):66. PubMed ID: 38336746
[TBL] [Abstract][Full Text] [Related]
2. MiR-1306-5p promotes cell proliferation and inhibits cell apoptosis in acute myeloid leukemia by downregulating PHF6 expression.
Gao X; Fan S; Zhang X
Leuk Res; 2022 Sep; 120():106906. PubMed ID: 35780573
[TBL] [Abstract][Full Text] [Related]
3. PHF6 suppresses self-renewal of leukemic stem cells in AML.
Jalnapurkar SS; Pawar A; George SS; Antony C; Grana J; Gurbuxani S; Paralkar VR
bioRxiv; 2024 Jan; ():. PubMed ID: 38260439
[TBL] [Abstract][Full Text] [Related]
4. PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway.
Hou S; Wang X; Guo T; Lan Y; Yuan S; Yang S; Zhao F; Fang A; Liu N; Yang W; Chu Y; Jiang E; Cheng T; Sun X; Yuan W
Leukemia; 2023 Aug; 37(8):1626-1637. PubMed ID: 37393343
[TBL] [Abstract][Full Text] [Related]
5. The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.
Eisa YA; Guo Y; Yang FC
Stem Cell Rev Rep; 2023 Jan; 19(1):67-75. PubMed ID: 36008597
[TBL] [Abstract][Full Text] [Related]
6. PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.
Tsai HI; Wu Y; Huang R; Su D; Wu Y; Liu X; Wang L; Xu Z; Pang Y; Sun C; He C; Shu F; Zhu H; Wang D; Cheng F; Huang L; Chen H
Acta Pharm Sin B; 2022 Apr; 12(4):1913-1927. PubMed ID: 35847518
[TBL] [Abstract][Full Text] [Related]
7. PHF6 mutations in adult acute myeloid leukemia.
Van Vlierberghe P; Patel J; Abdel-Wahab O; Lobry C; Hedvat CV; Balbin M; Nicolas C; Payer AR; Fernandez HF; Tallman MS; Paietta E; Melnick A; Vandenberghe P; Speleman F; Aifantis I; Cools J; Levine R; Ferrando A
Leukemia; 2011 Jan; 25(1):130-4. PubMed ID: 21030981
[TBL] [Abstract][Full Text] [Related]
8. R274X-mutated Phf6 increased the self-renewal and skewed T cell differentiation of hematopoietic stem cells.
Lan Y; Yuan S; Guo T; Hou S; Zhao F; Yang W; Cao Y; Chu Y; Jiang E; Yuan W; Wang X
iScience; 2023 Jun; 26(6):106817. PubMed ID: 37288345
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma.
Yoo NJ; Kim YR; Lee SH
Acta Oncol; 2012 Jan; 51(1):107-11. PubMed ID: 21736506
[TBL] [Abstract][Full Text] [Related]
10. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
[TBL] [Abstract][Full Text] [Related]
11.
Kurzer JH; Weinberg OK
Front Oncol; 2021; 11():704471. PubMed ID: 34381727
[TBL] [Abstract][Full Text] [Related]
12. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
[TBL] [Abstract][Full Text] [Related]
13. PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression.
Yuan S; Wang X; Hou S; Guo T; Lan Y; Yang S; Zhao F; Gao J; Wang Y; Chu Y; Shi J; Cheng T; Yuan W
Leukemia; 2022 Feb; 36(2):370-382. PubMed ID: 34465864
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.
Mets E; Van Peer G; Van der Meulen J; Boice M; Taghon T; Goossens S; Mestdagh P; Benoit Y; De Moerloose B; Van Roy N; Poppe B; Vandesompele J; Wendel HG; Van Vlierberghe P; Speleman F; Rondou P
Haematologica; 2014 Aug; 99(8):1326-33. PubMed ID: 24895337
[TBL] [Abstract][Full Text] [Related]
15. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.
Liu Z; Li F; Ruan K; Zhang J; Mei Y; Wu J; Shi Y
J Biol Chem; 2014 Apr; 289(14):10069-83. PubMed ID: 24554700
[TBL] [Abstract][Full Text] [Related]
17. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials.
Hsu YC; Chen TC; Lin CC; Yuan CT; Hsu CL; Hou HA; Kao CJ; Chuang PH; Chen YR; Chou WC; Tien HF
Blood Adv; 2019 Aug; 3(15):2355-2367. PubMed ID: 31395598
[No Abstract] [Full Text] [Related]
18. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
19. PHF6 mutation is associated with poor outcome in acute myeloid leukaemia.
Huang K; Wang L; Zheng Y; Yue C; Xu X; Chen H; Huang R; Li Y
Cancer Med; 2023 Feb; 12(3):2795-2804. PubMed ID: 36176187
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
